TNL Mediagene [TNMG] vs New York Times [NYT] Detailed Stock Comparison
TNL Mediagene
NASDAQ
Loading...
New York Times
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: TNL Mediagene wins in 5 metrics, New York Times wins in 8 metrics, with 0 ties. New York Times appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | TNL Mediagene | New York Times | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 29.79 | N/A |
| Price-to-Book Ratio | 0.31 | 4.84 | TNL Mediagene |
| Debt-to-Equity Ratio | 0.64 | 0.00 | New York Times |
| PEG Ratio | N/A | 27.64 | N/A |
| EV/EBITDA | -0.73 | 18.54 | TNL Mediagene |
| Profit Margin (TTM) | 36.58% | 12.04% | TNL Mediagene |
| Operating Margin (TTM) | -159.10% | 15.62% | New York Times |
| EBITDA Margin (TTM) | N/A | 15.62% | N/A |
| Return on Equity | -233.51% | 17.13% | New York Times |
| Return on Assets (TTM) | -91.49% | 9.09% | New York Times |
| Free Cash Flow (TTM) | $-10.58M | $381.34M | New York Times |
| Dividend Yield | N/A | 1.05% | N/A |
| 1-Year Return | -96.33% | 6.52% | New York Times |
| Price-to-Sales Ratio (TTM) | 0.26 | 3.52 | TNL Mediagene |
| Enterprise Value | $32.30M | $8.82B | New York Times |
| EV/Revenue Ratio | 0.67 | 3.31 | TNL Mediagene |
| Gross Profit Margin (TTM) | N/A | 50.61% | N/A |
| Revenue per Share (TTM) | N/A | $16 | N/A |
| Earnings per Share (Diluted) | $-3.46 | $1.93 | New York Times |
| Beta (Stock Volatility) | N/A | 1.09 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
TNL Mediagene vs New York Times Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| TNL Mediagene | 0.47% | 4.88% | -6.52% | 38.71% | -82.08% | -94.18% |
| New York Times | -1.20% | 9.94% | 1.91% | 9.28% | 16.71% | 9.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| TNL Mediagene | -96.33% | -96.33% | -96.33% | -96.33% | -96.33% | -96.33% |
| New York Times | 6.52% | 70.39% | 29.16% | 344.97% | 645.65% | 83.09% |
Performance & Financial Health Analysis: TNL Mediagene vs New York Times
| Metric | TNMG | NYT |
|---|---|---|
| Market Information | ||
| Market Cap | $12.81M | $9.36B |
| Market Cap Category | Micro cap | Mid cap |
| 10 Day Avg. Volume | 314,398 | 2,864,710 |
| 90 Day Avg. Volume | 190,499 | 2,108,270 |
| Last Close | $0.43 | $57.49 |
| 52 Week Range | $0.26 - $34.08 | $44.83 - $62.24 |
| % from 52W High | -98.75% | -7.63% |
| All-Time High | $34.08 (Dec 02, 2024) | $62.24 (Aug 07, 2025) |
| % from All-Time High | -98.74% | -7.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.10% |
| Quarterly Earnings Growth | N/A | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.37% | 0.12% |
| Operating Margin (TTM) | -1.59% | 0.16% |
| Return on Equity (TTM) | -2.34% | 0.17% |
| Debt to Equity (MRQ) | 0.64 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.39 | $11.87 |
| Cash per Share (MRQ) | N/A | $3.32 |
| Operating Cash Flow (TTM) | $-36,835,261 | $489.93M |
| Levered Free Cash Flow (TTM) | $-85,004,692 | $401.88M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.05% |
| Last 12-Month Dividend | N/A | $0.57 |
Valuation & Enterprise Metrics Analysis: TNL Mediagene vs New York Times
| Metric | TNMG | NYT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 29.79 |
| Forward P/E | N/A | 27.64 |
| PEG Ratio | N/A | 27.64 |
| Price to Sales (TTM) | 0.26 | 3.52 |
| Price to Book (MRQ) | 0.31 | 4.84 |
| Market Capitalization | ||
| Market Capitalization | $12.81M | $9.36B |
| Enterprise Value | $32.30M | $8.82B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.67 | 3.31 |
| Enterprise to EBITDA | -0.73 | 18.54 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.09 |
| Book Value per Share (MRQ) | $1.39 | $11.87 |
Financial Statements Comparison: TNL Mediagene vs New York Times
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TNMG | NYT |
|---|---|---|
| Revenue/Sales | N/A | $635.91M |
| Cost of Goods Sold | N/A | $334.64M |
| Gross Profit | N/A | $301.27M |
| Research & Development | N/A | $66.54M |
| Operating Income (EBIT) | N/A | $67.48M |
| EBITDA | N/A | $92.32M |
| Pre-Tax Income | N/A | $63.97M |
| Income Tax | N/A | $14.42M |
| Net Income (Profit) | N/A | $49.55M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TNMG | NYT |
|---|---|---|
| Cash & Equivalents | $3.65M | $182.60M |
| Total Current Assets | $17.72M | $801.57M |
| Total Current Liabilities | $32.99M | $554.85M |
| Long-Term Debt | $10.39M | N/A |
| Total Shareholders Equity | $36.40M | $1.88B |
| Retained Earnings | $-117.21M | $2.35B |
| Property, Plant & Equipment | $100,203 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TNMG | NYT |
|---|---|---|
| Operating Cash Flow | N/A | $97.11M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $89.85M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-58.96M |
Short Interest & Institutional Ownership Analysis
| Metric | TNMG | NYT |
|---|---|---|
| Shares Short | 54,828 | 9.42M |
| Short Ratio | 0.02 | 6.04 |
| Short % of Float | N/A | 0.06% |
| Average Daily Volume (10 Day) | 314,398 | 2,864,710 |
| Average Daily Volume (90 Day) | 190,499 | 2,108,270 |
| Shares Outstanding | 26.10M | 163.77M |
| Float Shares | N/A | 151.67M |
| % Held by Insiders | 0.00% | 0.02% |
| % Held by Institutions | 0.01% | 0.98% |
Dividend Analysis & Yield Comparison: TNL Mediagene vs New York Times
| Metric | TNMG | NYT |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.57 |
| Last 12-Month Dividend Yield | N/A | 1.05% |
| 3-Year Avg Annual Dividend | N/A | $0.47 |
| 3-Year Avg Dividend Yield | N/A | 0.28% |
| 3-Year Total Dividends | N/A | $1.41 |
| Ex-Dividend Date | N/A | Apr 01, 2025 |